Co-infusion of mesenchymal stromal cells to prevent GVHD after allogeneic hematopoietic cell transplantation from HLA-mismatched unrelated donors after reduced-intensity conditioning: a double-blind randomized study and literature review
Abstract Background Mesenchymal stromal cells (MSC) have immunomodulatory and hematopoiesis-supporting properties that could potentially benefit hematopoietic stem cell (HSC) engraftment and decrease the incidence and/or severity of graft-versus-host disease (GVHD). Methods Based on our previous pil...
Saved in:
Main Authors: | Gérôme Lombardo, Chantal Lechanteur, Alexandra Briquet, Laurence Seidel, Evelyne Willems, Sophie Servais, Etienne Baudoux, Tessa Kerre, Pierre Zachee, Julie Herman, Audrey Janssen, Joséphine Muller, Frédéric Baron, Yves Beguin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13287-024-04064-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
by: Ke Zeng, et al.
Published: (2024-12-01) -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR
by: Selim SAYIN
Published: (2024-02-01) -
Low dose ATG-Fresenius for GVHD prophylaxis: a comparative study with ATG-Thymoglobulin
by: Itai Falicovich, et al.
Published: (2025-01-01) -
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
by: Jochen T. Frueh, et al.
Published: (2024-12-01) -
Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context
by: Valentine Wang, et al.
Published: (2025-01-01)